It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Faculty	Relationship Identified With:
Rany Aburashed, DO	Consultant/Advisor: Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech, Inc.; Novartis AG; Sanofi Genzyme Grant/Research Support: Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech, Inc.; Novartis AG; Sanofi Genzyme
Joseph R. Berger, MD	Consultant/Advisor: Bristol Myers Squibb; Cellevolve; EMD Serono; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Morphic Therapeutics, Inc.; Novartis AG; Sanofi; Takeda Pharmaceutical Company Limited; TG Therapeutics, Inc. Data Safety Management: Mapi-Pharma Ltd Scientific Advisor: Excision BioTherapeutics
Jeffrey Cohen, MD	Consultant/Advisor: Astoria; Bristol Myers Squibb; Convelo Therapeutics, Inc.; EMD Serono; Find Therapeutics; INmuneBIO; Sandoz Editor: SAGE/Multiple Sclerosis Journal
Fiona Costello, MD	Consultant/Advisor: Alexion Pharmaceuticals, Inc.; Horizon Therapeutics plc; Sanofi
Patricia K. Coyle, MD	Consultant/Advisor: Accordant; Biogen; Bristol Myers Squibb; EMD Serono; Lilly; GlaxoSmithKline; Genentech, Inc.; Horizon Therapeutics plc; Laboratory Corporation of America; Mylan Specialty L.P., a Viatris Company; Novartis AG; Sanofi Grant/Research Support: Bristol Myers Squibb; CorEvitas LLC; Genentech, Inc.; National Institute of Neurological Disorders and Stroke; Sanofi
Rachel Dorsey-Campbell, BPharm, MRPharmS, MFRPSII, NMP	Consultant/Advisor: Biogen; Merck & Co.; Novartis AG; Roche; Sanofi Genzyme Speaker’s Bureau: Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech, Inc.; Novartis AG; Sanofi Genzyme
Mark S. Freedman, MD	Consultant/Advisor: Alexion Pharmaceuticals, Inc.; Amgen Inc.; AstraZeneca; Atara Biotherapeutics, Inc.; Bayer AG; Biogen-Idec; Celestra Health; EMD Serono; Find Therapeutics, F. Hoffman La-Roche; Horizon Therapeutics plc; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis, AG; Neurogenesis, Inc.; Sandoz; Sanofi; Sentrex Health Solutions; SetPoint Medical; Teva Canada Innovation Grant/Research Support: Sanofi-Genzyme Canada Speaker’s Bureau: EMD Serono; F. Hoffman La-Roche; Novartis AG
Prof. Gavin Giovannoni	Consultant/Advisor: AbbVie, Inc.; Actelion; ASLAN Pharmaceuticals; Atara Biotherapeutics, Inc.; Biogen; Bristol Myers Squibb Company; Celgene Corporation; EMD Serono, Inc.; Genentech, Inc.; GlaxoSmithKline plc.; GW Pharmaceuticals plc; Janssen Pharmaceuticals Inc.; Japan Tobacco; LIFNano Rx Limited; Merck & Co.; Merck KGaA; Novartis AG; Roche; Sanofi Genzyme; Teva Pharmaceuticals Speaker’s Bureau: AbbVie, Inc.; Actelion; Biogen; Bristol Myers Squibb Company; Celgene Corporation; EMD Serono, Inc.; Genentech, Inc.; Janssen Pharmaceuticals Inc.; Jazz Pharmaceuticals, Inc.; Merck KGaA; Novartis AG; Roche; Sanofi Genzyme
Dr. Benjamin Greenberg	Consultant/Advisor: Alexion; Cycle Pharma; EMD Serono; Genentech/Roche; Genzyme; Horizon Therapeutics; Immunovant; IQVIA; Novartis; Sandoz; Signant Grant/Research Support: Anokion; Clene Nanomedicine; NIH; Regeneron
Jaime Imitola, MD	Consultant/Advisor: Biogen; Novartis AG Grant/Research Support: Biogen
Stephen Krieger, MD	Consultant/Advisor: Baim Institute; Biogen; Cycle Pharmaceuticals Limited; EMD Serono, Genentech, Inc.; Novartis AG; Octave Bioscience, Inc; Sanofi; TG Therapeutics, Inc. Grant/Research Support: Biogen; Bristol Myers Squibb; Novartis AG; Sanofi Non-Promotional Speaking: Biogen; EMD Serono; Genentech, Inc.; TG Therapeutics, Inc.
Sarah Levy, PhD	Nothing to Disclose
Fred D. Lublin, MD	Consultant/Advisor: Abata Therapeutics; Amgen Inc.; Avotres Inc.; Baim Institute; Banner Life Sciences; Biogen; Biohaven, Ltd.; Brainstorm Cell Limited; Bristol Myers Squibb; Cognito Therapeutics; EMD Serono; Entelexo, Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Horizon Therapeutics plc; Immunic, Inc.; Janssen Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Laboratory Corporation of America; LAPIX Therapeutics; Mapi Pharma Lid; Mylan Specialty L.P., a Viatris Company; NeuraLight; Neurogene Inc.; Novartis AG; Sandoz; Sanofi; SetPoint Medical; Sudo Biosciences, Inc.; Teva Pharmaceutical Industries Ltd Grant/Research Support: Biogen; Brainstorm Cell Limited; National Institutes of Health; National MS Society; Novartis AG; Sanofi Stock Options: Avotres, Inc.; Entelexo, Inc.; LAPIX Therapeutics; NeuraLight Speaker: Sanofi
Clyde Markowitz, MD	Consultant/Advisor: Alexion Pharmaceuticals, Inc.; ANI; Banner Life Sciences; Biogen; Bristol Myers Squibb; Cycle Pharmaceuticals Limited; EMD Serono; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Sanofi; Horizon Therapeutics plc; Janssen Pharmaceuticals, Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd; TG Therapeutics, Inc.
Aaron Miller, MD	Consultant/Advisor: Accordant; Amgen, Inc.; CorEvitas, LLC; Mapi-Pharma Ltd ; Mylan Specialty L.P., a Viatris Company Speaker: Alexion Pharmaceuticals, Inc.; Amgen, Inc.; Biogen
Robert Naismith, MD	Consultant/Advisor: Alexion Pharmaceuticals, Inc.; Biogen; Bristol Myers Squibb; Celltrion, Genentech, Inc.; Horizon Therapeutics plc; Janssen Pharmaceuticals, Inc.; Lundbeck; Sanofi; TG Therapeutics, Inc.
Jacqueline Nicholas, MD, MPH	Consultant/Advisor: Alexion Pharmaceuticals; EMD Serono, Inc.; Genentech, Inc.; Greenwich Biosciences, Inc.; Novartis AG; TG Therapeutics Grant/Research Support: Biogen Speaker’s Bureau: Alexion Pharmaceuticals; EMD Serono, Inc.; Genentech, Inc.
Jiwon Oh, MD, PhD	Consultant/Advisor: Biogen-Idec; EMD Serono; F. Hoffmann-La Roche Ltd; Horizon Therapeutics plc; Lilly; Novartis AG; Sandoz; Sanofi
Daniel Ontaneda, MD, PhD	Consultant/Advisor: Biogen-Idec; Bristol Myers Squibb; Continuem Therapeutics; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Novartis AG Grant Research Support: Bristol Myers Squibb; Genentech, Inc.; National Institutes of Health; National Multiple Sclerosis Society; Novartis AG; Patient Centered Outcomes Research Institute; Race to Erase MS Foundation; Sanofi
Gabriel Pardo, MD, FAAN	Consultant/Advisor: EMD Serono; TG Therapeutics; Horizon Therapeutics; Novartis Pharmaceuticals; Greenwich Pharmaceuticals; Bristol Myers Squibb/Celgene Speaker’s Bureau: Biogen Idec; EMD Serono; Roche/Genentech; Sanofi Genzyme; Novartis Pharmaceuticals; Janssen; Celgene; Prime Education Stock: Progentec Diagnostics Grant/Research Support: Biogen Idec; Roche/Genentech; Sanofi Genzyme; Novartis Pharmaceuticals; EMD Serono; Abbvie; Bristol Myers Squibb/Celgene
Amy Perrin Ross, APN, MSN, CNRN, MSCN	Consultant/Advisor: Alexion Pharmaceuticals, Inc.; Bristol Myers Squibb; EMD Serono; Horizon Therapeutics plc; Sandoz; Sanofi; TG Therapeutics, Inc.; UCB
Benjamin Segal, MD	Consultant/Advisor: EMD Serono; Lilly
Barry Singer, MD	Consultant/Advisor: AbbVie, Inc.; Alexion Pharmaceuticals; Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Janssen Pharmaceuticals Inc.; Genentech, Inc.; Greenwich Biosciences, Inc.; Novartis AG; Roche; Sanofi Genzyme; TG Therapeutics Grant/Research Support: AbbVie, Inc.; Alkermes; Biogen; Greenwich Biosciences, Inc.; Medimmune, LLC; Novartis AG; Roche; Sanofi Genzyme
Mitzi Joi Williams, MD	Consultant/Advisor: AbbVie, Inc.; Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech, Inc.; Novartis AG; Sanofi Genzyme Grant/Research Support: EMD Serono, Inc.; Genentech, Inc.; Novartis AG
Mary Alissa Willis, MD	Consultant/Advisor: Genentech, Inc.; Greenwich Biosciences, Inc. Grant/Research Support: Alexion Pharmaceuticals; Biogen; Bristol Myers Squibb Company; Genentech, Inc.

All relevant financial relationships with ineligible companies for this educational content have been mitigated.